Work

Phase I study of obatoclax mesylate (GX15–070MS), a bcl-2 antagonist, plus topotecan in relapsed small cell lung carcinoma and other solid tumors

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.3504

Authors: A. B. Brown, C. Rudin, N. Rizvi, W. Travis, N. Takebe, L. P. James, S. Subzwari, L. Tyson, S. Markus, L. M. Krug

Institutions: National Institutes of Health, Memorial Sloan Kettering Cancer Center, Johns Hopkins University, National Cancer Institute

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2245349746

Cites:

Cited by: 4

Related to: 10